Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 35

1.

New mechanisms of resistance in virological failure to protease inhibitors: selection of non-described protease, Gag and Gp41 mutations.

Castain L, Perrier M, Charpentier C, Palich R, Desire N, Wirden M, Descamps D, Sayon S, Landman R, Valantin MA, Joly V, Peytavin G, Yazdanpanah Y, Katlama C, Calvez V, Marcelin AG, Todesco E.

J Antimicrob Chemother. 2019 Jul 1;74(7):2019-2023. doi: 10.1093/jac/dkz151.

PMID:
31050739
2.

Predicting Wellness After Pediatric Concussion.

Beauchamp MH, Tang K, Yeates KO, Anderson P, Brooks BL, Keightley M, Désiré N, Boutis K, Gagnon I, Gravel J, Dubrovsky AS, Zemek R; 5P PERC Concussion Team.

J Int Neuropsychol Soc. 2019 Apr;25(4):375-389. doi: 10.1017/S1355617719000286.

PMID:
31050335
3.

Characterization update of HIV-1 M subtypes diversity and proposal for subtypes A and D sub-subtypes reclassification.

Désiré N, Cerutti L, Le Hingrat Q, Perrier M, Emler S, Calvez V, Descamps D, Marcelin AG, Hué S, Visseaux B.

Retrovirology. 2018 Dec 22;15(1):80. doi: 10.1186/s12977-018-0461-y.

4.

Predicting Psychological Distress after Pediatric Concussion.

Brooks BL, Plourde V, Beauchamp MH, Tang K, Yeates KO, Keightley M, Anderson P, Désiré N, Barrowman N, Zemek R; PERC Concussion Team.

J Neurotrauma. 2019 Mar 1;36(5):679-685. doi: 10.1089/neu.2018.5792. Epub 2018 Oct 10.

PMID:
30032719
5.

Prevalence and clinical impact of minority resistant variants in patients failing an integrase inhibitor-based regimen by ultra-deep sequencing.

Nguyen T, Fofana DB, Lê MP, Charpentier C, Peytavin G, Wirden M, Lambert-Niclot S, Desire N, Grude M, Morand-Joubert L, Flandre P, Katlama C, Descamps D, Calvez V, Todesco E, Marcelin AG.

J Antimicrob Chemother. 2018 Sep 1;73(9):2485-2492. doi: 10.1093/jac/dky198.

PMID:
29873733
6.

Evaluation of different analysis pipelines for the detection of HIV-1 minority resistant variants.

Perrier M, Désiré N, Storto A, Todesco E, Rodriguez C, Bertine M, Le Hingrat Q, Visseaux B, Calvez V, Descamps D, Marcelin AG, Charpentier C.

PLoS One. 2018 Jun 1;13(6):e0198334. doi: 10.1371/journal.pone.0198334. eCollection 2018.

7.

Predictors of neuropsychological outcome after pediatric concussion.

Beauchamp MH, Aglipay M, Yeates KO, Désiré N, Keightley M, Anderson P, Brooks BL, Barrowman N, Gravel J, Boutis K, Gagnon I, Dubrovsky AS, Zemek R.

Neuropsychology. 2018 May;32(4):495-508. doi: 10.1037/neu0000419.

PMID:
29809036
8.

Disparities in HIV-1 transmitted drug resistance detected by ultradeep sequencing between men who have sex with men and heterosexual populations.

Todesco E, Charpentier C, Bertine M, Wirden M, Storto A, Desire N, Grude M, Nguyen T, Sayon S, Yazdanpanah Y, Katlama C, Descamps D, Calvez V, Marcelin AG.

HIV Med. 2017 Oct;18(9):696-700. doi: 10.1111/hiv.12508. Epub 2017 Apr 26.

9.

HIV-1 diagnosis with unquantifiable viraemia: don't be naive, look for antiretroviral drugs.

Wirden M, Charpentier C, Tubiana R, Le MP, Desire N, Dionou S, Pichon F, Valantin MA, Yasdanpanah Y, Descamps D, Peytavin G, Katlama C, Calvez V, Marcelin AG.

J Antimicrob Chemother. 2017 Feb;72(2):630-632. doi: 10.1093/jac/dkw474. Epub 2016 Dec 20. No abstract available.

PMID:
27999067
10.

TLR-2 Recognizes Propionibacterium acnes CAMP Factor 1 from Highly Inflammatory Strains.

Lheure C, Grange PA, Ollagnier G, Morand P, Désiré N, Sayon S, Corvec S, Raingeaud J, Marcelin AG, Calvez V, Khammari A, Batteux F, Dréno B, Dupin N.

PLoS One. 2016 Nov 30;11(11):e0167237. doi: 10.1371/journal.pone.0167237. eCollection 2016.

11.

Complementary assays for monitoring susceptibility of varicella-zoster virus resistance to antivirals.

Perrier M, Désiré N, Deback C, Agut H, Boutolleau D, Burrel S.

J Virol Methods. 2016 Jul;233:10-4. doi: 10.1016/j.jviromet.2016.03.006. Epub 2016 Mar 16.

PMID:
26994966
12.

Genetic Diversity within Alphaherpesviruses: Characterization of a Novel Variant of Herpes Simplex Virus 2.

Burrel S, Désiré N, Marlet J, Dacheux L, Seang S, Caumes E, Bourhy H, Agut H, Boutolleau D.

J Virol. 2015 Dec;89(24):12273-83. doi: 10.1128/JVI.01959-15. Epub 2015 Sep 23.

13.

Definition of an HBsAg to DNA international unit conversion factor by enrichment of circulating hepatitis B virus forms.

Désiré N, Ngo Y, Franetich JF, Dembele L, Mazier D, Vaillant JC, Poynard T, Thibault V.

J Viral Hepat. 2015 Sep;22(9):718-26. doi: 10.1111/jvh.12387. Epub 2015 Jan 29.

PMID:
25644062
14.

Improved detection of resistance at failure to a tenofovir, emtricitabine and efavirenz regimen by ultradeep sequencing.

Todesco E, Rodriguez C, Morand-Joubert L, Mercier-Darty M, Desire N, Wirden M, Girard PM, Katlama C, Calvez V, Marcelin AG.

J Antimicrob Chemother. 2015 May;70(5):1503-6. doi: 10.1093/jac/dku557. Epub 2015 Jan 21.

PMID:
25614045
15.

Coexistence of circulating HBsAg and anti-HBs antibodies in chronic hepatitis B carriers is not a simple analytical artifact and does not influence HBsAg quantification.

Pancher M, Désiré N, Ngo Y, Akhavan S, Pallier C, Poynard T, Thibault V.

J Clin Virol. 2015 Jan;62:32-7. doi: 10.1016/j.jcv.2014.11.015. Epub 2014 Nov 18.

16.

Genetic barrier for attachment inhibitor BMS-626529 resistance in HIV-1 B and non-B subtypes.

Fofana DB, Charpentier C, Maïga AI, Lambert-Niclot S, Sayon S, Désiré N, Simon A, Yazdanpanah Y, Katlama C, Descamps D, Calvez V, Marcelin AG, Soulié C.

J Antimicrob Chemother. 2015 Jan;70(1):130-5. doi: 10.1093/jac/dku360. Epub 2014 Sep 30.

PMID:
25270328
17.

Impact of HIV-1 infection on herpes simplex virus type 2 genetic variability among co-infected individuals.

Abrão EP, Burrel S, Désiré N, Bonnafous P, Godet A, Caumes E, Agut H, Boutolleau D.

J Med Virol. 2015 Mar;87(3):357-65. doi: 10.1002/jmv.24061. Epub 2014 Sep 1.

PMID:
25174847
18.

Could droplet digital PCR be used instead of real-time PCR for quantitative detection of the hepatitis B virus genome in plasma?

Boizeau L, Laperche S, Désiré N, Jourdain C, Thibault V, Servant-Delmas A.

J Clin Microbiol. 2014 Sep;52(9):3497-8. doi: 10.1128/JCM.01306-14. Epub 2014 Jul 2. No abstract available.

19.

Role of genotype G hepatitis B virus mixed infection on the progression of hepatic fibrosis in HIV positive patients over 5 years of follow-up.

Calin R, Guiguet M, Desire N, Imbert-Bismut F, Munteanu M, Poynard T, Valantin MA, Stitou H, Katlama C, Thibault V.

J Clin Virol. 2013 Oct;58(2):408-14. doi: 10.1016/j.jcv.2013.07.018. Epub 2013 Aug 6.

PMID:
23958588
20.

Detection of a new variant of herpes simplex virus type 2 among HIV-1-infected individuals.

Burrel S, Abrao EP, Désiré N, Seang S, Caumes E, Agut H, Boutolleau D.

J Clin Virol. 2013 Jul;57(3):267-9. doi: 10.1016/j.jcv.2013.03.008. Epub 2013 Apr 5. No abstract available.

PMID:
23567026
21.

Production of hepatitis B defective particles is dependent on liver status.

Redelsperger F, Lekbaby B, Mandouri Y, Giang E, Duriez M, Desire N, Roque Afonso AM, Brichler S, Dubreuil P, Dobrin A, Perlemuter G, Prevot S, Bacon N, Grange JD, Zatla F, Le Pendeven C, Pol S, Strick-Marchand H, Di Santo J, Kremsdorf D, Soussan P.

Virology. 2012 Sep 15-30;431(1-2):21-8. doi: 10.1016/j.virol.2012.05.008. Epub 2012 Jun 2.

22.

Six-year follow-up of hepatitis B surface antigen concentrations in tenofovir disoproxil fumarate treated HIV-HBV-coinfected patients.

Thibault V, Stitou H, Desire N, Valantin MA, Tubiana R, Katlama C.

Antivir Ther. 2011;16(2):199-205. doi: 10.3851/IMP1723.

PMID:
21447869
23.

[Development and validation of a specific method for relative HBV-genotype G (G-HBV) quantification in the context of co-infection with other genotypes].

Désiré N, Sanchis T, Ben Moussa F, Stitou H, Katlama C, Thibault V.

Pathol Biol (Paris). 2011 Apr;59(2):e13-9. doi: 10.1016/j.patbio.2010.07.005. Epub 2010 Sep 6. French.

PMID:
20822865
24.

Long-term follow-up of 11 protease inhibitor (PI)-naïve and PI-treated HIV-infected patients harbouring virus with insertions in the HIV-1 protease gene.

Amiel C, Charpentier C, Désiré N, Bonnard P, Lebrette MG, Weiss L, Pialoux G, Schneider V.

HIV Med. 2011 Mar;12(3):138-44. doi: 10.1111/j.1468-1293.2010.00862.x. Epub 2010 Aug 15.

25.

Real-time PCR quantification of genital shedding of herpes simplex virus (HSV) and human immunodeficiency virus (HIV) in women coinfected with HSV and HIV.

Legoff J, Bouhlal H, Grésenguet G, Weiss H, Khonde N, Hocini H, Désiré N, Si-Mohamed A, de Dieu Longo J, Chemin C, Frost E, Pépin J, Malkin JE, Mayaud P, Bélec L.

J Clin Microbiol. 2006 Feb;44(2):423-32.

26.

A new insertion in the HIV-1 reverse transcriptase gene inducing major resistance to non-nucleoside reverse transcriptase inhibitors.

Amiel C, Desire N, Schneider V, Delphin N, Race E, Clavel F, Piolot T, Dam E, Rozenbaum W, Nicolas JC.

AIDS. 2005 Nov 4;19(16):1922-4.

PMID:
16227805
27.

Detection and quantitation of BK virus DNA by real-time polymerase chain reaction in the LT-ag gene in adult renal transplant recipients.

Si-Mohamed A, Goff JL, Désiré N, Maylin S, Glotz D, Bélec L.

J Virol Methods. 2006 Jan;131(1):21-7. Epub 2005 Aug 19.

PMID:
16112754
28.

Evaluation of HTLV-I removal by filtration of blood cell components in a routine setting.

Césaire R, Kérob-Bauchet B, Bourdonné O, Maier H, Amar KO, Halbout P, Dehée A, Désiré N, Dantin F, Béra O, Lézin A.

Transfusion. 2004 Jan;44(1):42-8.

PMID:
14692966
29.

Quantitation of HTLV-I proviral load by a TaqMan real-time PCR assay.

Dehée A, Césaire R, Désiré N, Lézin A, Bourdonné O, Béra O, Plumelle Y, Smadja D, Nicolas JC.

J Virol Methods. 2002 Apr;102(1-2):37-51.

PMID:
11879691
30.

Quantification of HTLV type I and HIV type I DNA load in coinfected patients: HIV type 1 infection does not alter HTLV type I proviral amount in the peripheral blood compartment.

Césaire R, Dehée A, Lézin A, Désiré N, Bourdonné O, Dantin F, Béra O, Smadja D, Abel S, Cabié A, Sobesky G, Nicolas JC.

AIDS Res Hum Retroviruses. 2001 Jun 10;17(9):799-805.

PMID:
11429121
31.

Quantification of human immunodeficiency virus type 1 proviral load by a TaqMan real-time PCR assay.

Désiré N, Dehée A, Schneider V, Jacomet C, Goujon C, Girard PM, Rozenbaum W, Nicolas JC.

J Clin Microbiol. 2001 Apr;39(4):1303-10.

32.

Human T cell leukemia virus Type I (HTLV-I) infection induces greater expansions of CD8 T lymphocytes in persons with HTLV-I-associated myelopathy/tropical spastic paraparesis than in asymptomatic carriers.

Ureta-Vidal A, Pique C, Garcia Z, Dehée A, Tortevoye P, Désiré N, Gessain A, Chancerel B, Gout O, Lemonnier FA, Cochet M.

J Infect Dis. 2001 Mar 15;183(6):857-64. Epub 2001 Feb 13.

PMID:
11237801
33.

Quantitative analysis of human herpesvirus 8 viral load using a real-time PCR assay.

Lallemand F, Desire N, Rozenbaum W, Nicolas JC, Marechal V.

J Clin Microbiol. 2000 Apr;38(4):1404-8.

34.

Study of mother-to-child Epstein-Barr virus transmission by means of nested PCRs.

Meyohas MC, Maréchal V, Desire N, Bouillie J, Frottier J, Nicolas JC.

J Virol. 1996 Oct;70(10):6816-9.

35.

[Preimplantation diagnosis of delta F508 mutation of mucoviscidosis in transgenic mice].

Ji YZ, Nicolas JC, Marechal V, Desire N, Pavirani A, Milliez J.

Presse Med. 1995 Sep 16;24(26):1193-7. French.

PMID:
7567845

Supplemental Content

Loading ...
Support Center